ClearPoint Neuro CLPT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.55M-58.5% | -$7.79M-44.6% | -$5.89M-18.4% | -$5.84M-32.4% | -$6.03M-45.3% | ||
| $86K-16.5% | $249K+3.8% | $66K-75.0% | $396K+70.0% | $103K-57.6% | ||
| $2.22M+16.2% | $1.98M+16.3% | $2.02M+6.2% | $2.27M+26.3% | $1.91M+26.9% | ||
| $42K— | $23K— | $39K+77.3% | $21K+50.0% | $0-100% | ||
| -$95K-144% | —— | —— | —— | $217K+249% | ||
| $2.02M+339% | $765K-27.1% | -$260K-165% | $609K+1.2% | -$846K0.0% | ||
| $125K+260% | $87K+128% | $498K+166% | -$404K-208% | -$78K-47.2% | ||
| -$437K+84.8% | -$6.27M-462% | —— | —— | -$2.88M-210% | ||
| -$653K-289% | —— | $560K+247% | $304K-33.8% | -$168K-1.8% | ||
| $172K+130% | -$250K— | —— | —— | -$581K+60.3% | ||
| $504K— | —— | —— | —— | $0— | ||
| -$391K-67.1% | -$296K-26.5% | -$245K-4.7% | -$237K-3.0% | -$234K-36.8% | ||
| -$7.97M-29.1% | -$12.06M-870% | -$3.12M-160% | -$2.55M+4.3% | -$6.17M-60.7% | ||
| $645K+252% | $49K-81.4% | $199K+1,558% | $91K— | $183K— | ||
| —— | $284.25K— | $284.25K— | $284.25K— | $284.25K— | ||
| -$645K-252% | $1.09M+514% | -$199K-1,558% | -$91K— | -$183K— | ||
| $148K— | —— | —— | $3.26M— | $0-100% | ||
| $1.99M+52.7% | $195K+132% | $0-100% | $356K+178% | $1.31M+764% | ||
| -$1.85M-35.5% | $19.56M+52,776% | $0— | $31.98M+19,886% | -$1.36M-108% | ||
| -$10.46M-35.5% | $8.57M+684% | —— | $29.33M+1,270% | -$7.72M-163% | ||
| $525K— | $418K— | $318K+189% | $172K-7.0% | $0-100% | ||
| $0— | $0-100% | $57K— | $12K-70.7% | $0— | ||
| $42K— | $23K— | $39K+77.3% | $21K+50.0% | $0-100% | ||
| $504K— | —— | —— | —— | $0— | ||
| -$391K-67.1% | -$296K-26.5% | -$245K-4.7% | -$237K-3.0% | -$234K-36.8% | ||
| $71K— | $3K— | $192K+19,100% | $0— | $0-100% | ||
| -$653K-289% | —— | $560K+247% | $304K-33.8% | -$168K-1.8% | ||
| $525K— | $418K— | $318K— | $172K— | $0— | ||
| -$95K-144% | —— | —— | —— | $217K+249% | ||
| $0-100% | —— | —— | —— | $78K— | ||
| $172K+130% | -$250K— | —— | —— | -$581K+60.3% | ||
| -$391K-67.1% | -$296K-26.5% | -$245K-4.7% | -$237K-3.0% | -$234K-36.8% | ||
| -$8.61M-35.5% | -$12.1M-704% | -$3.32M-174% | -$2.64M+0.9% | -$6.36M-65.5% | ||
| -$8.61M-35.5% | -$12.1M-704% | -$3.32M-174% | -$2.64M+0.9% | -$6.36M-65.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ClearPoint Neuro generate?
- ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
- What is ClearPoint Neuro's free cash flow?
- After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
- Where does ClearPoint Neuro's cash flow data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
